Noi biomarkeri pentru detectarea infecţiilor bacteriene la pacienţii cu ciroză
Închide
Conţinutul numărului revistei
Articolul precedent
Articolul urmator
851 20
Ultima descărcare din IBN:
2023-05-03 22:45
Căutarea după subiecte
similare conform CZU
616.36-004-002:616.94-07 (1)
Patologia sistemului digestiv. Tulburări ale tubului alimentar (1698)
Boli transmisibile. Boli infecţionase şi contagioase, stări febrile (575)
SM ISO690:2012
ARDELEANU, Denis, TCACIUC, Eugen, PROCA, Nicolae, BUGOR, Kalina, PITEL, Ecaterina, BERLIBA, Elina. Noi biomarkeri pentru detectarea infecţiilor bacteriene la pacienţii cu ciroză. In: Sănătate Publică, Economie şi Management în Medicină , 2017, nr. 3(73), pp. 56-58. ISSN 1729-8687.
EXPORT metadate:
Google Scholar
Crossref
CERIF

DataCite
Dublin Core
Sănătate Publică, Economie şi Management în Medicină
Numărul 3(73) / 2017 / ISSN 1729-8687 /ISSNe 2587-3873

Noi biomarkeri pentru detectarea infecţiilor bacteriene la pacienţii cu ciroză

New biomarkers to detect bacterial infections in patients with cirrhosis

CZU: 616.36-004-002:616.94-07

Pag. 56-58

Ardeleanu Denis1, Tcaciuc Eugen2, Proca Nicolae1, Bugor Kalina1, Pitel Ecaterina1, Berliba Elina2
 
1 IMSP Spitalul Clinic Republican „Timofei Moșneaga”,
2 Universitatea de Stat de Medicină şi Farmacie „Nicolae Testemiţanu“
 
Disponibil în IBN: 31 octombrie 2017


Rezumat

Life expectancy of patients with liver cirrhosis is closely linked to the degree of liver dysfunction and the occurrence of bacterial infection. An early diagnosis of infection helps to initiate adequate and timely measures and improves outcome of cirrhotic patients. New determinants of prognosis in patients with liver cirrhosis and bacterial infections have been identified in recent years. Recent changes in epidemiology and new findings in pathophysiology have been reported. This review deals with the new determinants of prognosis in patients with cirrhosis and bacterial infections reported recently. It has been reported an association between endothelial dysfunction and higher portal pressure and more episodes of decompensation of cirrhosis. In summary, endothelial dysfunction is clearly associated with poor prognosis and vWF should be taken into account in predictive models in hospitalized patients. The present article provides several lines of evidence to suggest that endocan acts as mediator of inflammatory state associated with bacterial infection in liver cirrhosis, and larger prospective studies should investigate the practical clinical value of serum endocam measurements.